Detailed Information

Thermalaze is 'the new skin technology'- non-surgical facelifts, skin tightening, skin resurfacing & facial rejuvenation.

The Thermalaze Programme is the most significant advancement in facial & body rejuvenation giving clients with ageing or problematic skin conditions excellent combinational results at the same time. If you are aspiring to look years younger with a non-surgical facelift and a revitalising skin resurfacing, then the Thermalaze Programme is your non surgical makeover solution.

Take up to ten years off your appearance with clinically proven techniques & technology, capable of the combinational results of skin tightening (i.e. non surgical facelift, body skin tightening) and skin resurfacing. Patients of any age (18 to 85) and of any skin severity may now be treated.

Thermalaze treatments can be tailored to your individual needs - a cosmetic skin assessment by our doctor helps decide which Thermalaze Programme will maximize the results you are aspiring to achieve. Whether you want to simply refresh & rejuvenate your skin, or you want to treat severe signs of ageing & skin damage (e.g. loose sagging skin, skin laxity, excess skin, ageing skin, sun-damaged skin, deep wrinkles, eyelid hooding, baggy eyes, acne scars, surgery scars, keloid scars, pigmentation, sun damaged skin, melasma, rosacea, stretch marks etc), Thermalaze is the cosmedical solution for your problematic skin.

Thermalaze is the safest non-invasive skin procedure, which involves no surgery or general anaesthesia, and has minimal downtime. This skin tightening and resurfacing treatment the only patented technology available which is capable of penetrating the entire skin depth & therefore capable of achieving excellent face lifting, neck lifting, skin tightening, skin repair, anti ageing & skin rejuvenation. The results of Thermalaze long lasting (3 to 5 years) to permanent. Only 1 to 2 treatments are required in most patients. Thermalaze treatment results appear immediately & continue to improve with time, with a clinically demonstrated 98 % treatment success rate.